{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:03:46Z","timestamp":1784365426702,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000055","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["R01DC012545"],"award-info":[{"award-number":["R01DC012545"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Oral medications for the treatment of dystonia are not established. Currently, symptoms of focal dystonia are managed with botulinum toxin injections into the affected muscles. However, the injection effects are short-lived and not beneficial for all patients. We recently reported significant clinical improvement of symptoms with novel investigational oral drug, sodium oxybate, in patients with the alcohol-responsive form of laryngeal focal dystonia. Understanding the mechanism of action of this promising oral agent holds a strong potential for the development of a scientific rationale for its use in dystonia. Therefore, to determine the neural markers of sodium oxybate effects, which may underlie dystonic symptom improvement, we examined brain activity during symptomatic speech production before and after drug intake in patients with laryngeal dystonia and compared to healthy subjects. We found that sodium oxybate significantly attenuated hyperfunctional activity of cerebellar, thalamic and primary\/secondary sensorimotor cortical regions. Drug-induced symptom improvement was correlated with decreased-to-normal levels of activity in the right cerebellum. These findings suggest that sodium oxybate shows direct modulatory effects on disorder pathophysiology by acting upon abnormal neural activity within the dystonic network.<\/jats:p>","DOI":"10.1038\/s41598-018-34553-x","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T10:08:23Z","timestamp":1540462103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["A novel therapeutic agent, sodium oxybate, improves dystonic symptoms via reduced network-wide activity"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7444-0437","authenticated-orcid":false,"given":"Kristina","family":"Simonyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Frucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Blitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azadeh Hamzehei","family":"Sichani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna F.","family":"Rumbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,31]]},"reference":[{"key":"34553_CR1","doi-asserted-by":"crossref","unstructured":"Kirke D. N. et al. Neural correlates of dystonic tremor: a multimodal study of voice tremor in spasmodic dysphonia. Brain Imaging Behav. Feb 3. [Epub ahead of print] (2016).","DOI":"10.1007\/s11682-016-9513-x"},{"issue":"Suppl 1","key":"34553_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1468-1331.2010.03047.x","volume":"17","author":"A Blitzer","year":"2010","unstructured":"Blitzer, A. Spasmodic dysphonia and botulinum toxin: experience from the largest treatment series. Eur J Neurol. 17(Suppl 1), 28\u201330 (2010).","journal-title":"Eur J Neurol."},{"issue":"3","key":"34553_CR3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/lary.21395","volume":"121","author":"D Novakovic","year":"2011","unstructured":"Novakovic, D., Waters, H. H., D\u2019Elia, J. B. & Blitzer, A. Botulinum toxin treatment of adductor spasmodic dysphonia: longitudinal functional outcomes. Laryngoscope. 121(3), 606\u2013612 (2011).","journal-title":"Laryngoscope."},{"issue":"6","key":"34553_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1212\/WNL.0000000000003596","volume":"88","author":"S Pirio Richardson","year":"2017","unstructured":"Pirio Richardson, S. et al. Dystonia treatment: Patterns of medication use in an international cohort. Neurology. 88(6), 543\u2013550 (2017).","journal-title":"Neurology."},{"issue":"2","key":"34553_CR5","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1007\/s00415-015-7751-2","volume":"262","author":"DN Kirke","year":"2015","unstructured":"Kirke, D. N., Frucht, S. J. & Simonyan, K. Alcohol responsiveness in laryngeal dystonia: a survey study. J Neurol. 262(2), 1548\u20131556 (2015).","journal-title":"J Neurol."},{"issue":"4457","key":"34553_CR6","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1126\/science.7394531","volume":"209","author":"JN Nestoros","year":"1980","unstructured":"Nestoros, J. N. Ethanol specifically potentiates GABA-mediated neurotransmission in feline cerebral cortex. Science. 209(4457), 708\u2013710 (1980).","journal-title":"Science."},{"issue":"2","key":"34553_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.nbd.2010.08.025","volume":"42","author":"M Hallett","year":"2011","unstructured":"Hallett, M. Neurophysiology of dystonia: The role of inhibition. Neurobiol Dis. 42(2), 177\u2013184 (2011).","journal-title":"Neurobiol Dis."},{"issue":"1","key":"34553_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/ana.10073","volume":"51","author":"LM Levy","year":"2002","unstructured":"Levy, L. M. & Hallett, M. Impaired brain GABA in focal dystonia. Ann Neurol. 51(1), 93\u2013101 (2002).","journal-title":"Ann Neurol."},{"issue":"7","key":"34553_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1002\/mds.25532","volume":"28","author":"A Quartarone","year":"2013","unstructured":"Quartarone, A. & Hallett, M. Emerging concepts in the physiological basis of dystonia. Mov Disord. 28(7), 958\u2013967 (2013).","journal-title":"Mov Disord."},{"key":"34553_CR10","doi-asserted-by":"crossref","unstructured":"Simonyan, K. Inferior parietal cortex as a hub of loss of inhibutuib and maladaptive plasticity. Paper presented at: Annual Meeting of Americal ACademy of Neurology; Boston (2017).","DOI":"10.1212\/WNL.88.16_supplement.S39.002"},{"key":"34553_CR11","doi-asserted-by":"crossref","unstructured":"Rumbach, A. F., Blitzer, A., Frucht, S. J. & Simonyan, K. An open-label study of sodium oxybate in Spasmodic dysphonia. Laryngoscope. 2016.","DOI":"10.1002\/lary.26381"},{"key":"34553_CR12","doi-asserted-by":"crossref","unstructured":"Simonyan, K. & Frucht, S. J. Long-term Effect of Sodium Oxybate (Xyrem(R)) in Spasmodic Dysphonia with Vocal Tremor. Tremor and other hyperkinetic movements. 3. eCollection 2013 (2013)","DOI":"10.5334\/tohm.156"},{"issue":"1","key":"34553_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1211\/0022357022511","volume":"56","author":"A Waszkielewicz","year":"2004","unstructured":"Waszkielewicz, A. & Bojarski, J. Gamma-hydrobutyric acid (GHB) and its chemical modifications: a review of the GHBergic system. Pol J Pharmacol. 56(1), 43\u201349 (2004).","journal-title":"Pol J Pharmacol."},{"issue":"4","key":"34553_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5664\/jcsm.27549","volume":"5","author":"YG Wang","year":"2009","unstructured":"Wang, Y. G., Swick, T. J., Carter, L. P., Thorpy, M. J. & Benowitz, N. L. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion. J Clin Sleep Med. 5(4), 365\u2013371 (2009).","journal-title":"J Clin Sleep Med."},{"issue":"5","key":"34553_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1044\/1092-4388(2006\/081)","volume":"49","author":"SO Ali","year":"2006","unstructured":"Ali, S. O. et al. Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study. J Speech Lang Hear Res. 49(5), 1127\u20131146 (2006).","journal-title":"J Speech Lang Hear Res."},{"key":"34553_CR16","doi-asserted-by":"crossref","unstructured":"Battistella, G., Fuertinger, S., Fleysher, L., Ozelius, L. J. & Simonyan, K. Cortical sensorimotor alterations classify clinical phenotype and putative genotype of spasmodic dysphonia. European journal of neurology. (2016).","DOI":"10.1111\/ene.13067"},{"issue":"10","key":"34553_CR17","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1212\/01.wnl.0000184478.59063.db","volume":"65","author":"B Haslinger","year":"2005","unstructured":"Haslinger, B. et al. \u201cSilent event-related\u201d fMRI reveals reduced sensorimotor activation in laryngeal dystonia. Neurology. 65(10), 1562\u20131569 (2005).","journal-title":"Neurology."},{"issue":"11","key":"34553_CR18","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1093\/cercor\/bhq023","volume":"20","author":"K Simonyan","year":"2010","unstructured":"Simonyan, K. & Ludlow, C. L. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study. Cereb Cortex. 20(11), 2749\u20132759 (2010).","journal-title":"Cereb Cortex."},{"key":"34553_CR19","doi-asserted-by":"crossref","unstructured":"Battistella, G., Termsarasab, P., Ramdhani, R. A., Fuertinger, S. & Simonyan, K. Isolated Focal Dystonia as a Disorder of Large-Scale Functional Networks. Cereb Cortex. pii: bhv313. [Epub ahead of print] (2015)","DOI":"10.1093\/cercor\/bhv313"},{"issue":"7","key":"34553_CR20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/mds.25527","volume":"28","author":"S Lehericy","year":"2013","unstructured":"Lehericy, S., Tijssen, M. A., Vidailhet, M., Kaji, R. & Meunier, S. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord. 28(7), 944\u2013957 (2013).","journal-title":"Mov Disord."},{"issue":"3","key":"34553_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.neuroimage.2011.02.045","volume":"56","author":"E Zoons","year":"2011","unstructured":"Zoons, E., Booij, J., Nederveen, A. J., Dijk, J. M. & Tijssen, M. A. Structural, functional and molecular imaging of the brain in primary focal dystonia\u2013a review. Neuroimage. 56(3), 1011\u20131020 (2011).","journal-title":"Neuroimage."},{"issue":"2","key":"34553_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/cercor\/bhr120","volume":"22","author":"K Simonyan","year":"2012","unstructured":"Simonyan, K. & Ludlow, C. L. Abnormal structure-function relationship in spasmodic dysphonia. Cereb Cortex. 22(2), 417\u2013425 (2012).","journal-title":"Cereb Cortex."},{"issue":"Pt 2","key":"34553_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/brain\/awm303","volume":"131","author":"K Simonyan","year":"2008","unstructured":"Simonyan, K. et al. Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain. 131(Pt 2), 447\u2013459 (2008).","journal-title":"Brain."},{"issue":"9","key":"34553_CR24","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/mds.25934","volume":"29","author":"RA Ramdhani","year":"2014","unstructured":"Ramdhani, R. A. et al. What\u2019s special about task in dystonia? A voxel-based morphometry and diffusion weighted imaging study. Mov Disord. 29(9), 1141\u20131150 (2014).","journal-title":"Mov Disord."},{"key":"34553_CR25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.parkreldis.2016.02.003","volume":"25","author":"VS Kostic","year":"2016","unstructured":"Kostic, V. S. et al. Brain structural changes in spasmodic dysphonia: A multimodal magnetic resonance imaging study. Parkinsonism Relat Disord. 25, 78\u201384 (2016).","journal-title":"Parkinsonism Relat Disord."},{"key":"34553_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2012.11.019","volume":"241","author":"CN Prudente","year":"2013","unstructured":"Prudente, C. N. et al. Neuropathology of cervical dystonia. Exp Neurol. 241, 95\u2013104 (2013).","journal-title":"Exp Neurol."},{"issue":"2","key":"34553_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/mds.870030209","volume":"3","author":"J Kulisevsky","year":"1988","unstructured":"Kulisevsky, J., Marti, M. J., Ferrer, I. & Tolosa, E. Meige syndrome: neuropathology of a case. Mov Disord. 3(2), 170\u2013175 (1988).","journal-title":"Mov Disord."},{"issue":"11","key":"34553_CR28","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1038\/nn1544","volume":"8","author":"E Hoshi","year":"2005","unstructured":"Hoshi, E., Tremblay, L., Feger, J., Carras, P. L. & Strick, P. L. The cerebellum communicates with the basal ganglia. Nat Neurosci. 8(11), 1491\u20131493 (2005).","journal-title":"Nat Neurosci."},{"issue":"18","key":"34553_CR29","doi-asserted-by":"publisher","first-page":"8452","DOI":"10.1073\/pnas.1000496107","volume":"107","author":"AC Bostan","year":"2010","unstructured":"Bostan, A. C., Dum, R. P. & Strick, P. L. The basal ganglia communicate with the cerebellum. Proc Natl Acad Sci USA 107(18), 8452\u20138456 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2\u20133","key":"34553_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S0165-0173(99)00040-5","volume":"31","author":"FA Middleton","year":"2000","unstructured":"Middleton, F. A. & Strick, P. L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res Brain Res Rev. 31(2\u20133), 236\u2013250 (2000).","journal-title":"Brain Res Brain Res Rev."},{"key":"34553_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1749-6632.2002.tb07575.x","volume":"978","author":"RP Dum","year":"2002","unstructured":"Dum, R. P., Li, C. & Strick, P. L. Motor and nonmotor domains in the monkey dentate. Ann N Y Acad Sci. 978, 289\u2013301 (2002).","journal-title":"Ann N Y Acad Sci."},{"issue":"4","key":"34553_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00221-008-1572-9","volume":"192","author":"F Brighina","year":"2009","unstructured":"Brighina, F. et al. Effects of cerebellar TMS on motor cortex of patients with focal dystonia: a preliminary report. Exp Brain Res. 192(4), 651\u2013656 (2009).","journal-title":"Exp Brain Res."},{"issue":"12","key":"34553_CR33","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1038\/nn.3868","volume":"17","author":"CH Chen","year":"2014","unstructured":"Chen, C. H., Fremont, R., Arteaga-Bracho, E. E. & Khodakhah, K. Short latency cerebellar modulation of the basal ganglia. Nat Neurosci. 17(12), 1767\u20131775 (2014).","journal-title":"Nat Neurosci."},{"issue":"5","key":"34553_CR34","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/mds.23553","volume":"26","author":"V Garibotto","year":"2011","unstructured":"Garibotto, V. et al. In vivo evidence for GABA(A) receptor changes in the sensorimotor system in primary dystonia. Mov Disord. 26(5), 852\u2013857 (2011).","journal-title":"Mov Disord."},{"key":"34553_CR35","first-page":"1","volume":"94","author":"M Hallett","year":"2004","unstructured":"Hallett, M. Dystonia: abnormal movements result from loss of inhibition. Adv Neurol. 94, 1\u20139 (2004).","journal-title":"Adv Neurol."},{"issue":"1","key":"34553_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coph.2005.10.001","volume":"6","author":"V Crunelli","year":"2006","unstructured":"Crunelli, V., Emri, Z. & Leresche, N. Unravelling the brain targets of gamma-hydroxybutyric acid. Curr Opin Pharmacol. 6(1), 44\u201352 (2006).","journal-title":"Curr Opin Pharmacol."},{"issue":"33","key":"34553_CR37","doi-asserted-by":"publisher","first-page":"13404","DOI":"10.1073\/pnas.1204376109","volume":"109","author":"N Absalom","year":"2012","unstructured":"Absalom, N. et al. alpha4betadelta GABA(A) receptors are high-affinity targets for gamma-hydroxybutyric acid (GHB). Proc Natl Acad Sci USA 109(33), 13404\u201313409 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"34553_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.otohns.2008.05.624","volume":"139","author":"CL Ludlow","year":"2008","unstructured":"Ludlow, C. L. et al. Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg. 139(4), 495\u2013505 (2008).","journal-title":"Otolaryngol Head Neck Surg."},{"issue":"2","key":"34553_CR39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0310057X0903700214","volume":"37","author":"R Arpesella","year":"2009","unstructured":"Arpesella, R. et al. A patient with intractable posthypoxic myoclonus (Lance-Adams syndrome) treated with sodium oxybate. Anaesthesia and intensive care. 37(2), 314\u2013318 (2009).","journal-title":"Anaesthesia and intensive care."},{"issue":"10","key":"34553_CR40","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/mds.20605","volume":"20","author":"SJ Frucht","year":"2005","unstructured":"Frucht, S. J., Bordelon, Y., Houghton, W. H. & Reardan, D. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord. 20(10), 1330\u20131337 (2005).","journal-title":"Mov Disord."},{"issue":"12","key":"34553_CR41","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1212\/01.wnl.0000188670.38576.bd","volume":"65","author":"SJ Frucht","year":"2005","unstructured":"Frucht, S. J., Houghton, W. C., Bordelon, Y., Greene, P. E. & Louis, E. D. A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology. 65(12), 1967\u20131969 (2005).","journal-title":"Neurology."},{"issue":"37","key":"34553_CR42","doi-asserted-by":"publisher","first-page":"14705","DOI":"10.1523\/JNEUROSCI.0407-13.2013","volume":"33","author":"K Simonyan","year":"2013","unstructured":"Simonyan, K., Berman, B. D., Herscovitch, P. & Hallett, M. Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia. J Neurosci. 33(37), 14705\u201314714 (2013).","journal-title":"J Neurosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34553-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34553-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T19:21:22Z","timestamp":1720725682000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-34553-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["34553"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-34553-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,31]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16111"}}